-
Mashup Score: 7Validate User - 2 month(s) ago
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
#Iptacopan was granted #FDA approval for the treatment of paroxysmal nocturnal hemoglobinuria (#PNH) in adult patients. It is the first oral #monotherapy to be approved for PNH and was granted based on the results of the phase III APPLY-PNH trial. https://t.co/m4oqfkKc8e